Delivery Order SPE2DR25D1205-SPE2DR26F1AR8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,105.92 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion date of October 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies comprehensive pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Varivax vaccine with diluents, valued at $3,967.80 with a firm fixed price structure. The contract is not set-aside and is scheduled for completion by January 7, 2026. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $20,642.20 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 16, 2025. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $183,470.40 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract was awarded on January 20, 2026, with an ultimate completion date of February 10, 2026. The vaccine will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,233.70 to Amerisourcebergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was awarded on January 28, 2026, with an ultimate completion date of February 19, 2026, and employs firm fixed-price pricing with no set-aside designation. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,274.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on January 23, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of February 13, 2026. This is a competitively awarded contract with no set-aside designation, and performance will take place at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,548.22 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 3, 2026. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,106.02 for Varivax vaccine with diluents on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,367.32 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of January 29, 2026. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,975.85 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without set-aside designation on December 29, 2025, with an ultimate completion date of January 21, 2026. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed price terms. This delivery order is a child contract issued against AmerisourceBergen's...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AR8Delivery Order
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $3,822.30 on January 27, 2026, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 18, 2026, to be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc., which operates as Amerisourcebergen, holds the primary $999,999,999.00 IDC with DLA through December 31, 2031, serving as a comprehensive global pharmaceutical support vehicle. These contracts enable the company to supply an extensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 1/26/26 |